Showing results (61-70 of 1,864) with videos related to

Sort By:
Pageof 187
Clinical Oral Investigations|March 18, 2008
Modeling mucosal dimensions after implantation of a bio-absorbable membrane for surgical root coverageHans-Peter Müller
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 2, 2026
Rudolf Buchheim Award 2026: solanidine as a dietary derived CYP2D6 biomarkerJulian Peter Müller
Clinical Oral Investigations|December 17, 2008
Dealing with hierarchical data in periodontal researchHans-Peter Müller
Clinical Oral Investigations|August 16, 2008
Multilevel modeling of gingival bleeding on probing in young adult carriers of non-JP2-like strains of Aggregatibacter actinomycetemcomitansHans-Peter Müller
Advanced Materials (Deerfield Beach, Fla.)|March 29, 2014
The active layer morphology of organic solar cells probed with grazing incidence scattering techniquesPeter Müller-Buschbaum
The Annals of Thoracic Surgery|January 24, 2009
Prior inferior myocardial infarction has worse early outcomes in patients undergoing coronary artery bypass grafting than prior anterior myocardial infarctionToshihiro Fukui, Tomoki Shimokawa, Susumu Manabe, et al.
Anesthesia and Analgesia|June 13, 2013
Reevaluation of the effectiveness of ramosetron for preventing postoperative nausea and vomiting: a systematic review and meta-analysisTakahiro Mihara, Kentaro Tojo, Kazuhiro Uchimoto, et al.
Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology|January 15, 2021
Subacute thyroiditis presenting with creeping in a 6-year-old boyTatsuro Nakamura, Haruna Kakimoto, Satoshi Morita, et al.
Scientific Reports|November 3, 2021
Shorter duration of first-line chemotherapy reflects poorer outcomes in patients with HER2-negative advanced breast cancer: a multicenter retrospective studyShogo Nakamoto, Junichiro Watanabe, Shoichiro Ohtani, et al.
BMC Cancer|January 4, 2022
Eribulin improved the overall survival from the initiation of first-line chemotherapy for HER2-negative advanced breast cancer: a multicenter retrospective studyShogo Nakamoto, Junichiro Watanabe, Shoichiro Ohtani, et al.
Pageof 187